DE60043442D1 - Ner aktiven phase und einer inaktiven phase - Google Patents

Ner aktiven phase und einer inaktiven phase

Info

Publication number
DE60043442D1
DE60043442D1 DE60043442T DE60043442T DE60043442D1 DE 60043442 D1 DE60043442 D1 DE 60043442D1 DE 60043442 T DE60043442 T DE 60043442T DE 60043442 T DE60043442 T DE 60043442T DE 60043442 D1 DE60043442 D1 DE 60043442D1
Authority
DE
Germany
Prior art keywords
phase
inactive
ner
tablets
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60043442T
Other languages
English (en)
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GALENIX DEVOLOPPEMENT
Original Assignee
GALENIX DEVOLOPPEMENT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GALENIX DEVOLOPPEMENT filed Critical GALENIX DEVOLOPPEMENT
Application granted granted Critical
Publication of DE60043442D1 publication Critical patent/DE60043442D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE60043442T 1999-08-06 2000-08-02 Ner aktiven phase und einer inaktiven phase Expired - Lifetime DE60043442D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910285A FR2797185B1 (fr) 1999-08-06 1999-08-06 Composition pharmaceutique flottante comprenant une phase active et une phase non active
PCT/FR2000/002223 WO2001010417A1 (fr) 1999-08-06 2000-08-02 Composition pharmaceutique flottante comprenant une phase active et une phase non active

Publications (1)

Publication Number Publication Date
DE60043442D1 true DE60043442D1 (de) 2010-01-14

Family

ID=9548990

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60043442T Expired - Lifetime DE60043442D1 (de) 1999-08-06 2000-08-02 Ner aktiven phase und einer inaktiven phase

Country Status (12)

Country Link
US (1) US7682629B1 (de)
EP (1) EP1206247B1 (de)
AT (1) ATE450254T1 (de)
AU (1) AU779036B2 (de)
BR (1) BR0013106A (de)
CA (1) CA2378988C (de)
DE (1) DE60043442D1 (de)
FR (1) FR2797185B1 (de)
HU (1) HUP0202764A3 (de)
IL (2) IL148003A0 (de)
NO (1) NO20020572L (de)
WO (1) WO2001010417A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1411901B1 (de) 2001-07-04 2010-08-18 Sun Pharma Advanced Research Company Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
BR0309691A (pt) * 2002-12-20 2005-08-02 Hoffmann La Roche Formulação de ibandronato em alta dose
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
US20080274180A1 (en) * 2005-08-30 2008-11-06 Nicholas Piramal India Limited Extended Release Pharmaceutical Composition of Metformin and a Process for Producing It
WO2010020098A1 (zh) 2008-08-18 2010-02-25 北京天衡药物研究院 胃滞留药物释出***及其制备方法和用途
JP5545952B2 (ja) * 2007-08-31 2014-07-09 第一三共株式会社 徐放性製剤及びその製造方法
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2967352B1 (fr) * 2010-11-12 2012-12-28 Unither Dev Comprime effervescent pour l'administration par voie orale de principes actifs
WO2015089420A1 (en) 2013-12-13 2015-06-18 Biogen Idec Ma Inc. Controlled release dosage form for once daily administration of dimethyl fumarate
WO2019126218A1 (en) * 2017-12-18 2019-06-27 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
US11337920B2 (en) 2017-12-18 2022-05-24 Tris Pharma, Inc. Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release
IL275312B1 (en) 2017-12-18 2024-05-01 Tris Pharma Inc GHB pharmacy preparations containing a system that creates a floating integrated penetrating polymer network

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
JPS62195323A (ja) 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
NO20020572L (no) 2002-04-03
CA2378988A1 (fr) 2001-02-15
HUP0202764A3 (en) 2004-05-28
FR2797185B1 (fr) 2001-10-26
US7682629B1 (en) 2010-03-23
BR0013106A (pt) 2002-07-23
CA2378988C (fr) 2012-04-17
FR2797185A1 (fr) 2001-02-09
WO2001010417A1 (fr) 2001-02-15
AU779036B2 (en) 2005-01-06
NO20020572D0 (no) 2002-02-05
ATE450254T1 (de) 2009-12-15
IL148003A0 (en) 2002-09-12
EP1206247B1 (de) 2009-12-02
AU6848700A (en) 2001-03-05
IL148003A (en) 2007-06-03
EP1206247A1 (de) 2002-05-22
HUP0202764A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
AP9901478A0 (en) Compounds for the treatment of ischemia.
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
DE60043442D1 (de) Ner aktiven phase und einer inaktiven phase
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
HUP0300246A2 (en) Delivery system
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
ATE259798T1 (de) Pharmazeutisch aktive verbindungen
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
WO2001041737A3 (en) Solid oral dosage form
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
IS5600A (is) Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
DE69908399D1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
ZA200007010B (en) Retarding formulations of active substances used for plant protection.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
GB9907571D0 (en) Compounds
NO20002114D0 (no) Bicykliske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
IT1307751B1 (it) Composizione di catalizzatore contenente fosfati per la preparazionedi poliesteri e procedimenti relativi.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition